| Activated T-follicular helper 2 cells are associated with disease activity in IgG4-related sclerosing cholangitis and pancreatitis T Cargill, M Makuch, R Sadler, LC Lighaam, R Peters, M van Ham, ... Clinical and Translational Gastroenterology 10 (4), e00020, 2019 | 37 | 2019 |
| Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease G Goodchild, RJR Peters, TN Cargill, H Martin, A Fadipe, M Leandro, ... Clinical Medicine 20 (3), e32, 2020 | 10 | 2020 |
| Correspondence on ‘The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease’ RJR Peters, H Martin, A Virdee, E Fryer, H Bungay, M Rodriguez-Justo, ... Annals of the Rheumatic Diseases 82 (9), e210-e210, 2023 | 6 | 2023 |
| A novel serum metabolomic panel distinguishes I g G4‐related sclerosing cholangitis from primary sclerosing cholangitis DE Radford‐Smith, EA Selvaraj, R Peters, M Orrell, J Bolon, DC Anthony, ... Liver International 42 (6), 1344-1354, 2022 | 5 | 2022 |
| An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity PAC Wing, NM Schmidt, R Peters, M Erdmann, R Brown, H Wang, ... PLoS Pathogens 19 (5), e1011323, 2023 | 3 | 2023 |
| Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch database W Liao, CAC Coupland, H Innes, P Jepsen, PC Matthews, C Campbell, ... EClinicalMedicine 59, 2023 | 2 | 2023 |
| An ACAT inhibitor regulates SARS-CoV-2 replication and antiviral T cell activity NM Schmidt, PAC Wing, R Peters, R Brown, H Wang, L Swadling, ... BioRxiv, 2022.04. 12.487988, 2022 | 2 | 2022 |
| Lymphoma in IgG4-related disease: should we be concerned? A Hussenbux, R Peters, C Manganis, E Fryer, H Bungay, J David, ... Journal of Hepatology 77, S329-S330, 2022 | | 2022 |
| An ACAT inhibitor regulates SARS-CoV-2 replication and antiviral T cell activity (preprint) NM Schmidt, PAC Wing, R Peters, R Brown, H Wang, L Swadling, ... | | 2022 |
| O04 Serum nuclear magnetic resonance metabolomic signature can discriminate immunoglobulin G4-related sclerosing cholangitis and primary sclerosing cholangitis E Selvaraj, D Radford-Smith, R Peters, K Lynch, D Anthony, M Pavlides, ... Gut 70 (Suppl 3), A2-A3, 2021 | | 2021 |
| P060 Rituximab as third line therapy in IgG4-Related Disease: experience from a multi-centre cohort CD Manganis, CX Lee, RJR Peters, J David, R Luqmani, S Savic, ... Gut 70 (Suppl 3), A45-A45, 2021 | | 2021 |
| Serum nuclear magnetic resonance metabolomic signature can discriminate between immunoglobulin G4-related sclerosing cholangitis and primary sclerosing cholangitis E Selvaraj, DE Radford-Smith, R Peters, M Orrell, K Lynch, DC Anthony, ... JOURNAL OF HEPATOLOGY 75, S418-S419, 2021 | | 2021 |
| P257 Real world experience of the new ACR-EULAR classification criteria for IgG4-related disease R Peters, H Martin, A Virdee, E Fryer, H Bungay, M Rodriguez-Justo, ... Gut 70 (Suppl 1), A174-A175, 2021 | | 2021 |
| A multi-disciplinary approach to igG4 related disease aids in diagnosis and management R Peters, G Goodchild, H Martin, T Cargill, A Fadipe, M Leandro, A Bailey, ... Journal of Hepatology 73, S487-S488, 2020 | | 2020 |
| Correction: Activated T-Follicular Helper 2 Cells Are Associated With Disease Activity in IgG4-Related Sclerosing Cholangitis and Pancreatitis T Cargill, M Makuch, R Sadler, LC Lighaam, R Peters, M van Ham, ... Clinical and translational gastroenterology 10 (7), e00069, 2019 | | 2019 |
| PTU-100 The role of a multi-regional specialist multi-disciplinary meeting in diagnosis and management of igg4-related disease G Goodchild, R Peters, T Cargill, A Fadipe, M Leando, R Luqmani, ... Gut 68 (Suppl 2), A240, 2019 | | 2019 |
| PTU-041 Single centre study evaluating a hybrid network solution for an upper gi bleed rota KK Yong, R Peters, J Marshall, A Ellis Gut 66 (Suppl 2), A71-A71, 2017 | | 2017 |
